Skip to content
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Switzerland

Pfizer asks Swiss OK for COVID-19 vaccine for children 12 to 15

epa08898702 An exterior view of a logo on a building of biopharmaceutical company Pfizer in Paris, France, 21 December 2020. The European Commission approved to use the Pfizer Biontech vaccine after the European Medicines Agency (EMA) gave the green light to European countries to start COVID-19 vaccinations in the coming days, following regulatory approval for the use of a shot jointly developed by US company Pfizer and its German partner BioNTech. EPA-EFE/Julien de Rosa

ZURICH, May 7 (Reuters) – Pfizer has sought Swiss regulatory approval for its COVID-19 vaccine in children aged 12 to 15, regulator Swissmedic said on Friday. It is currently authorised for people aged 16 and over.

“Swissmedic will review the application in the rolling procedure. Pfizer can submit the latest data continuously without having to wait for the conclusive results from the clinical studies,” the watchdog said on its website.

Swissmedic also said it granted Swiss drugmaker Novartis an establishment licence for filling and packaging the vaccine at a plant in Switzerland.

(Reporting by Michael Shields, editing by John Revill)

Filed under Switzerland

More from Switzerland

More →